BASF India Ltd
BASF India Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
What the Q4 FY26 call signalled
1 of 3 strong
Not discussed on this call: fundraise, order book.
The short version
India’s chemical market is expected to grow gradually, supported by a young demographic and low per capita chemical consumption relative to global averages (Page 9). BASF India's EBITDA has remained in a similar range over six years (Rs.
From BASF India Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- India’s chemical market is expected to grow gradually, supported by a young demographic and low per capita chemical consumption relative to global averages (Page 9).
- BASF aims to expand its share across diverse industries including fast-moving consumer goods, construction chemicals, automotive, furniture, appliances, footwear, packaging (Page 12).
- Agricultural solutions volume growth was negative in FY26 due to challenging market conditions, but BASF maintained market share (~7%) and expanded in fruits and vegetables segments (Page 11).
- The company launched 12 new agro products in the last four years, contributing ~25% of ag division sales, signaling portfolio freshness and potential growth (Page 11).
- Capital expenditure (~Rs. 200+ crore in FY27) on expansions like Celesto and dispersion line capacity increases indicates growth investment (Page 10).
- BASF emphasizes profitable and sustainable growth amid competitive and macroeconomic pressures (Page 11).
- Forward-looking volume/pricing forecasts for agro remain uncertain due to external factors (Page 10).
Profitability & Margins
See what BASF India Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- FY26 Capex was around Rs. 200 crore, including Rs. 150 crore spent on Celesto expansion (ongoing).
- Celesto expansion is halfway complete; another Rs. 150-170 crore pending to bring it to production by end of FY27.
- Dispersion line 3 in Mangalore is a significant Capex project, targeted for commissioning by end of FY28, adding ~15% capacity.
- Maintenance Capex averages Rs. 82-100 crore annually, varies year to year.
- No large new Capex similar to the 2014 multi-OD site Dahej investment is currently planned.
- The focus is on maximizing utilization of existing assets and incremental capacity growth rather than large-scale investments due to global industry challenges (energy costs, overcapacity, geopolitical risks).
- BASF is expanding global service hubs in Hyderabad (digital and business services), reflecting strategic investment in India beyond manufacturing.
- BASF India is continually evaluating future opportunities but no definitive large Capex announcements yet.
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what BASF India Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
BASF India Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹3.5K Cr, net profit ₹64 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What BASF India Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- NOCIL Ltd (Q4 FY26)
The Rs.130 crores capex includes some intermediates and is largely for captive consumption, with part allocated to finished goods. Key concall takeaways from…
- Indo Borax & Ch. (Q4 FY26)
175 crores revenue in the previous financial year and Rs. Key concall takeaways from Indo Borax & Chemicals Ltd's Q4 FY26 earnings call — and how it ranks…
- Rossari Biotech Ltd (Q4 FY26)
50-70 crore planned for FY27 focused on pharma and aroma chemical facilities to support value-added product segments. Key concall takeaways from Rossari…
- Pidilite Inds. (Q4 FY26)
Underlying volume growth (UVG) averaged over 9% per quarter last year, with a ~200 bps increase in FY '25; the company plans to continue lifting UVG…
Frequently Asked Questions
What were BASF India Ltd Q4 FY26 results?
India’s chemical market is expected to grow gradually, supported by a young demographic and low per capita chemical consumption relative to global averages (Page 9). BASF India's EBITDA has remained in a similar range over six years (Rs.
What is BASF India Ltd share price analysis?
BASF India Ltd currently shows a neutral. The stock trades at a P/E of 28.2 with a market cap of ₹17,473 Cr. Investors should review the full earnings analysis for detailed insights.
Is BASF India Ltd planning capital expenditure?
FY26 Capex was around Rs.
Keep BASF India Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.